The Wall Street Journal
Pharmaceuticals & Biotech
-
The Wall Street Journal
Pharmaceuticals & Biotech
-
-
Loading…
-
Loading…
-
Loading…
-
Loading…
-
Loading…
-
Loading…
-
Loading…
-
Loading…
-
Loading…
-
Loading…
-
Loading…
-
Loading…
- Asia
- Europe
- Earnings
- Economy
- Health
- Law
- Autos
- Management
- Media & Marketing
- Energy
- CFO Journal
-
Pharmaceutical & Biotech
- Accounting
- Advertising
- Airlines
- Banking
- Broadcasting & Entertainment
- Chemicals
- Computer Hardware
- Computer Software
- Consumer Products
- Defense & Aerospace
- Financial Services & Insurance
- Food & Tobacco
- Hospitality
- Industrial Goods & Services
- Marketing & Strategy
- Media Agencies
- Metals & Mining
- Paper & Forest Products
- Pharmaceutical & Biotech
- Real Estate
- Retail
- Semiconductors
- Telecommunications
- Transportation
- Utilities
-
Subscriber Content Read Preview
Hospital Medical Devices to Go Wireless
The FCC is expected to vote to open up spectrum, easing patient monitoring and making corporate product development less risky.
-
Long-Lasting Birth Control Cuts Pregnancy Rate
A study confirms that long-acting forms of contraception such as intrauterine devices are better than birth control pills and patches at preventing pregnancies, giving doctors new ammunition to recommend these methods.
-
Subscriber Content Read Preview
Medtronic's Earnings Rise
Medtronic reported higher profit and sales for its latest quarter despite continuing challenges in key heart- and spinal-device markets.
-
Subscriber Content Read Preview
Dialysis Firm Bets on Branching Out
Dialysis provider DaVita agreed to buy doctor-network operator HealthCare Partners in a cash-and-stock deal valued at about $4.42 billion.
-
Subscriber Content Read Preview
Osteoporosis Drugs Linked to Fractures
Widely used osteoporosis drugs such as Fosamax and Actonel significantly raise the risk of a rare but serious thigh fracture, a new study found.
-
Subscriber Content Read Preview
Bayer-J&J Heart Drug Gains More Support
-
Subscriber Content Read Preview
Drug Plan Draws Fire in India
-
Subscriber Content Read Preview
Lawmakers To Vote on FDA Clout
-
Subscriber Content Read Preview
FDA Approves Generic Versions of Plavix
-
Subscriber Content Read Preview
Human Genome Adopts Poison Pill
-
More
Latest Pharmaceuticals & Biotech Headlines
-
US HOT STOCK FUTURES: HOT STOCKS TO WATCH
-
US HOT STOCK FUTURES: HOT STOCKS TO WATCH
-
US HOT STOCK FUTURES: HOT STOCKS TO WATCH
-
US HOT STOCK FUTURES: HOT STOCKS TO WATCH
-
Shoppers Drug Mart To Acquire Paragon Pharmacies For $75 Million
-
Shoppers Drug Mart To Acquire Paragon Pharmacies For $75 Mln
-
Humana Pharmacy Unit Seeks Customers Amid Industry Changes
-
AmerisourceBergen Raised To Conviction Buy From Buy By Goldman Sachs >ABC
-
New Corporate Bond Volume Slows; No Major Deals Wednesday
-
Moody's Lifts Cardinal Health Rating On Rising Generic Drug Sales
-
More Headlines »
More Industries
Subscriber Content
-
Accounting
-
Advertising
-
Airlines
-
Autos
-
Banking
-
Chemicals
-
Computer Hardware
-
Computer Software
-
Consumer Products
-
Defense & Aerospace
-
Energy
-
Entertainment
-
Financial Services & Insurance
-
Food & Tobacco
-
Health
-
Hospitality
-
Industrial Goods & Services
-
Internet & Online
-
Law
-
Marketing & Strategy
-
Media
-
Media & Marketing
-
Metals & Mining
-
Paper & Forest Products
-
Pharmaceutical & Biotech
-
Real Estate
-
Retailing
-
Semiconductors
-
Transportation
-
Utilities
Research Pharmaceutical & Biotech
View an interactive map that shows you how stocks in the Pharmaceuticals & Biotech sector are doing today, at a glance.
Get in-depth research on Pharmaceuticals & Biotech companies, including complete news and financials, earnings estimates and more.
- Financial Analyst (UnitedHealth Medicare And Retirement)-Horsham Pennsylvania - 380868 - UnitedHealth Group
- Senior Auto-Dialer Analyst - AT&T
- Banking & Capital Markets Advisory - Experienced Associate (Cap Mkts) - PricewaterhouseCoopers LLP
- Supply Chain Strategic Sourcing Professionals - Resources Global Professionals
Ask a Question
Ask a question about anything you choose, and let readers from the Journal Community answer it.
- *Required
Top Groups In Biotech
-
Question of the Day
Share your opinion on WSJ.com's question of the day.
Partner Center
An Advertising Feature- back to top
-
Customer Center:
Create an Account:
- Register for Limited Access
- Subscribe to WSJ.com
- Sign up for WSJ Professional
- Subscribe to WSJ Weekend - Print Edition
Help & Information Center:
-
About:
-
WSJ.com:
-
Tools & Formats:
-
Digital Network- WSJ.com
- Marketwatch.com
- Barrons.com
- SmartMoney.com
- AllThingsD.com
- FINS: Finance, IT jobs, Sales jobs
- BigCharts.com
- Virtual Stock Exchange
- WSJ Radio
- Professor Journal
- WSJ U.S. Edition
- WSJ Asia Edition
- WSJ Europe Edition
- WSJ India Page
Foreign language editions:
- WSJ Chinese
- WSJ Japanese
- WSJ Portuguese
- WSJ Spanish
- WSJ Deutschland
ACAP Enabled
Copyright ©2012 Dow Jones & Company, Inc. All Rights Reserved
Hello
Your question to the Journal Community Your comments on articles will show your real name and not a username.Why?
Create a Journal Community profile to avoid this message in the future. (As a member you agree to use your real name when participating in the Journal Community)